ADPT
Adaptive Biotechnologies Corp
NASDAQ · Healthcare · Biotechnology · US
$28.61
+0.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1775.94x
- P/S forward
- 14.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 31.95x
- Price / sales
- 14.82x
- Price / cash flow
- -217.34x
Enterprise value
- Enterprise value
- $4.6B
- EV / sales
- 15.06x
- EV / EBITDA
- -290.69x
- EV / EBIT
- -123.87x
- Market cap
- $4.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026